MedPath

A Clinical Pathway for Nursing Home Acquired Pneumonia

Not Applicable
Completed
Conditions
Lower Respiratory Tract Infection
Pneumonia
Interventions
Procedure: a clinical pathway nursing home acquired pneumonia
Registration Number
NCT00157612
Lead Sponsor
McMaster University
Brief Summary

Nursing home residents are frequently transferred to hospital for management of pneumonia. This often leads to hospital related complications and is a burden on the acute care health system. The purpose of this study is to assess whether managing residents with pneumonia and lower respiratory tract infection on site in the nursing home can reduce hospital admissions and can reduce complications and improve quality of life for residents. We have randomized residents with nursing home acquired pneumonia to on-site management, using a clinical pathway, versus usual care.

Detailed Description

We conducted a cluster-randomized controlled trial where nursing homes were randomized to either use of a clinical pathway or usual care for management of nursing home acquired pneumonia. The clinical pathway included chest radiographs performed on-site in the nursing home by a mobile x-ray unit, use of hypodermocylysis (subcutaneous infusion) for re-hydration, administration of an oral antimicrobials, and use of pulse oximetry to assess oxygenation. The main outcomes were hospital admission rate and length of stay. Secondary outcomes included health related quality of life, rates of both infectious and non-infectious complications within four weeks of onset of symptoms; mortality rate of residents with pneumonia (death from all causes within 30 days of onset of symptoms. Time to stabilization of vital signs, as well as functional status at four weeks, were assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
680
Inclusion Criteria
  • Symptoms or signs of lower respiratory tract infection as defined by standardized criteria.
Exclusion Criteria
  • Residents were excluded if they were not expected to live longer than 30 days from the date of enrollment, had a previous anaphylactic or serious allergic reaction to quinolones, had advanced directives that they are not be transferred to hospital for treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interventiona clinical pathway nursing home acquired pneumoniause of oral anti-microbials, portable chest radiographs, oxygen saturation monitoring, re-hydration and close monitoring by a research nurse
Primary Outcome Measures
NameTimeMethod
Hospital admission, length of stay
Secondary Outcome Measures
NameTimeMethod
functional status,
mortality,
time to stabilization of vital signs
complication rates,
Health related quality of life,
© Copyright 2025. All Rights Reserved by MedPath